pubmed.ncbi.nlm.nih.gov
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind,...
High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in reducing viral...